Maury Raycroft

Stock Analyst at Jefferies

(0)
# 4773
Out of 5,240 analysts
75
Total ratings
13.89%
Success rate
-23.37%
Average return
Main Sectors:
Top Industries:
41 Stocks
Name Action Price Target Current % Upside Ratings Updated
Sangamo Therapeutics
Maintains: Buy
7 3
1.09 175.23% 1 Dec 31, 2024
Mereo BioPharma Grou...
Initiates Coverage On: Buy
7
3.02 131.79% 1 Dec 6, 2024
Erasca
Initiates Coverage On: Buy
6
1.97 204.57% 1 Nov 18, 2024
Inozyme Pharma
Assumes: Strong Buy
16 17
1.5 1033.33% 1 Aug 13, 2024
Tango Therapeutics
Initiates Coverage On: Buy
19
2.75 590.91% 1 Jul 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
58 39
n/a n/a 2 May 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
23 15
2.78 439.57% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 39
20.21 92.97% 2 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.28 368.75% 1 Mar 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
4 46
12.21 276.74% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
2.87 701.39% 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
0.88 1604.55% 1 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 58
n/a n/a 7 Oct 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
11
7.36 49.46% 8 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
104 173
n/a n/a 3 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4 2
n/a n/a 1 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 9
0.89 911.24% 2 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
2.13 275.59% 1 Jan 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32 6
35.26 -82.98% 2 Jan 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 75
18.51 305.19% 4 Nov 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 36
n/a n/a 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
218 232
250.03 -7.21% 1 Oct 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
4.69 134.54% 1 Sep 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 20
n/a n/a 1 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
39 55
n/a n/a 1 Apr 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
31 27
16.39 64.73% 3 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
38 5
1.65 203.03% 2 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 17
n/a n/a 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
n/a n/a 1 Nov 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
48
10.75 346.51% 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
n/a n/a 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
36
4.36 725.69% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
105
3.14 3243.95% 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
172
39.72 333.03% 2 Apr 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
3.34 528.74% 1 Mar 31, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
n/a n/a 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
47
2.14 2096.26% 1 Feb 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 2
n/a n/a 2 Jan 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
18 40
1.1 3536.36% 5 Aug 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
230
6.27 3568.26% 1 Jul 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
36 42
9.86 325.96% 3 Nov 1, 2017